Positive and negative regulation of cellular immune responses in physiologic conditions and diseases

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Vigan, S ^a   Perreau, M ^a   Pantaleo, G ^a,b   Harari, A ^a,b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Swiss Vaccine Research Institute   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD150 ANTIGEN; CD160 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IPILIMUMAB; MONOCLONAL ANTIBODY; ONO 4538; PROGRAMMED DEATH 1 RECEPTOR; UNCLASSIFIED DRUG; T LYMPHOCYTE RECEPTOR;

AUTOIMMUNITY; CELL PROLIFERATION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT CANCER; REVIEW; T LYMPHOCYTE; UNSPECIFIED SIDE EFFECT; ANTIGEN PRESENTING CELL; BACTERIAL INFECTION; CLONAL ANERGY; CYTOLOGY; HOST PATHOGEN INTERACTION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MICROBIOLOGY; SIGNAL TRANSDUCTION; VIROLOGY; VIRUS INFECTION;

ANTIGEN-PRESENTING CELLS; BACTERIAL INFECTIONS; CLONAL ANERGY; COSTIMULATORY AND INHIBITORY T-CELL RECEPTORS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE SYSTEM; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; VIRUS DISEASES;

EID: 84859720182     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/485781     Document Type: Review

References (140)

1. Chen L., Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity Nature Reviews Immunology 2004 4 5 336 347 (Pubitemid 38649276)
2. Goodnow C. C., Sprent J., Groth F. de. S., Vinuesa C. G., Cellular and genetic mechanisms of self tolerance and autoimmunity Nature 2005 435 7042 590 597 (Pubitemid 40825498)
3. Bour-Jordan H., Esensten J. H., Martinez-Llordella M., Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/B7 family Immunological Reviews 2011 241 1 180 205
4. Fife B. T., Pauken K. E., The role of the PD-1 pathway in autoimmunity and peripheral tolerance Annals of the New York Academy of Sciences 2011 1217 1 45 59
5. Nurieva R. I., Liu X., Dong C., Molecular mechanisms of T-cell tolerance Immunological Reviews 2011 241 1 133 144
6. Curtsinger J. M., Lins D. C., Mescher M. F., Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function Journal of Experimental Medicine 2003 197 9 1141 1151 (Pubitemid 36570069)
7. Mempel T. R., Henrickson S. E., Von Andrian U. H., T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases Nature 2004 427 6970 154 159 (Pubitemid 38094955)
8. Curtsinger J. M., Johnson C. M., Mescher M. F., CD8 T cell clonal expansion and development of effector function require prolonged exposure to antigen, costimulation, and signal 3 cytokine Journal of Immunology 2003 171 10 5165 5171 (Pubitemid 37432800)
9. Leibson P. J., The regulation of lymphocyte activation by inhibitory receptors Current Opinion in Immunology 2004 16 3 328 336 (Pubitemid 38607380)
10. Wang N., Morra M., Wu C., Gullo C., Howie D., Coyle T., Engel P., Terhorst C., CD150 is a member of a family of genes that encode glycoproteins on the surface of hematopoietic cells Immunogenetics 2001 53 5 382 394 (Pubitemid 32762815)
11. Boles K. S., Stepp S. E., Bennett M., Kumar V., Mathew P. A., 2B4 (CD244) and CS1: novel members of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer cells and other leukocytes Immunological Reviews 2001 181 234 249 (Pubitemid 32703411)
12. Zhu C., Anderson A. C., Kuchroo V. K., TIM-3 and its regulatory role in immune responses Current topics in microbiology and immunology 2011 350 1 15
13. Rodriguez-Manzanet R., Dekruyff R., Kuchroo V. K., Umetsu D. T., The costimulatory role of TIM molecules Immunological Reviews 2009 229 1 259 270
14. Cai G., Freeman G. J., The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation Immunological Reviews 2009 229 1 244 258
15. Anumanthan A., Bensussan A., Boumsell L., Christ A. D., Blumberg R. S., Voss S. D., Patel A. T., Robertson M. J., Nadler L. M., Freeman G. J., Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes Journal of Immunology 1998 161 6 2780 2790 (Pubitemid 28425697)
16. Huard B., Gaulard P., Faure F., Hercend T., Triebel F., Cellular expression and tissue distribution of the human LAG-3-encoded protein, an MHC class II ligand Immunogenetics 1994 39 3 213 217 (Pubitemid 24014846)
17. Denoeud J., Moser M., Role of CD27/CD70 pathway of activation in immunity and tolerance Journal of Leukocyte Biology 2011 89 2 195 203
18. Goeken N. E., Differential stimulatory requirements and regulation of naive and primed human lymphocytes Human Immunology 1984 10 4 251 263 (Pubitemid 14045976)
19. Inaba K., Metlay J. P., Crowley M. T., Steinman R. M., Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ Journal of Experimental Medicine 1990 172 2 631 640 (Pubitemid 20248404)
20. Henrickson S. E., Mempel T. R., Mazo I. B., Liu B., Artyomov M. N., Zheng H., Peixoto A., Flynn M., Senman B., Junt T., Wong H. C., Chakraborty A. K., von Andrian U. H., In vivo imaging of T cell priming Science Signaling 2008 1 12 pt2
21. Henrickson S. E., Mempel T. R., Mazo I. B., Liu B., Artyomov M. N., Zheng H., Peixoto A., Flynn M. P., Senman B., Junt T., Wong H. C., Chakraborty A. K., von Andrian U. H., T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T cell activation Nature Immunology 2008 9 3 282 291 (Pubitemid 351267325)
22. Kaech S. M., Wherry E. J., Ahmed R., Effector and memory T-cell differentiation: implications for vaccine development Nature Reviews Immunology 2002 2 4 251 262 (Pubitemid 37323225)
23. Kaech S. M., Wherry E. J., Heterogeneity and Cell-fate decisions in effector and memory CD8 + t cell differentiation during viral infection Immunity 2007 27 3 393 405 (Pubitemid 47418674)
24. Mackay C. R., Marston W. L., Dudler L., Naive and memory T cells show distinct pathways of lymphocyte recirculation Journal of Experimental Medicine 1990 171 3 801 817 (Pubitemid 20088983)
25. Badovinac V. P., Harty J. T., Programming, demarcating, and manipulating CD8 + T-cell memory Immunological Reviews 2006 211 67 80 (Pubitemid 43882962)
26. Chambers C. A., Kuhns M. S., Egen J. G., Allison J. P., CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy Annual Review of Immunology 2001 19 565 594 (Pubitemid 32368046)
27. Hildeman D. A., Zhu Y., Mitchell T. C., Kappler J., Marrack P., Molecular mechanisms of activated T cell death in vivo Current Opinion in Immunology 2002 14 3 354 359 (Pubitemid 34327978)
28. Arnold R., Brenner D., Becker M., Frey C. R., Krammer P. H., How T lymphocytes switch between life and death European Journal of Immunology 2006 36 7 1654 1658 (Pubitemid 44089031)
29. Chen G., Tai A. K., Lin M., Chang F., Terhorst C., Huber B. T., Increased proliferation of CD8 + T cells in SAP-deficient mice is associated with impaired activation-induced cell death European Journal of Immunology 2007 37 3 663 674 (Pubitemid 46916933)
30. Mueller D. L., Mechanisms maintaining peripheral tolerance Nature Immunology 2010 11 1 21 27
31. Butz E. A., Bevan M. J., Massive expansion of antigen-specific CD8 + T cells during an acute virus infection Immunity 1998 8 2 167 175 (Pubitemid 28123744)
32. Harari A., Enders F. B., Cellerai C., Bart P. A., Pantaleo G., Distinct profiles of cytotoxic granules in memory CD8 T cells correlate with function, differentiation stage, and antigen exposure Journal of Virology 2009 83 7 2862 2871
33. Harari A., Dutoit V., Cellerai C., Bart P. A., Du Pasquier R. A., Pantaleo G., Functional signatures of protective antiviral T-cell immunity in human virus infections Immunological Reviews 2006 211 236 254 (Pubitemid 43882976)
34. Cellerai C., Perreau M., Rozot V., Enders F. B., Pantaleo G., Harari A., Proliferation capacity and cytotoxic activity are mediated by functionally and phenotypically distinct virus-specific CD8 T cells defined by interleukin-7R (CD127) and perforin expression Journal of Virology 2010 84 8 3868 3878
35. Harari A., Cellerai C., Enders F. B., Kstler J., Codarri L., Tapia G., Boyman O., Castro E., Gaudieri S., James I., John M., Wagner R., Mallal S., Pantaleo G., Skewed association of polyfunctional antigen-specific CD8 T cell populations with HLA-B genotype Proceedings of the National Academy of Sciences of the United States of America 2007 104 41 16233 16238 (Pubitemid 350099390)
36. Wherry E. J., T cell exhaustion Nature Immunology 2011 12 6 492 499
37. Brown M. H., Boles K., Van Der Merwe P. A., Kumar V., Mathew P. A., Barclay A. N., 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48 Journal of Experimental Medicine 1998 188 11 2083 2090 (Pubitemid 28562525)
38. Latchman Y., McKay P. F., Reiser H., Cutting edge: identification of the 2B4 molecule as a counter-receptor for CD48 Journal of Immunology 1998 161 11 5809 5812 (Pubitemid 28535943)
39. Cocks B. G., Chan C. C. J., Carballido J. M., Yssel H., De Vries J. E., Aversa G., A novel receptor involved in T-cell activation Nature 1995 376 6537 260 263
40. Howie D., Okamoto S., Rietdijk S., Clarke K., Wang N., Gullo C., Bruggeman J. P., Manning S., Coyle A. J., Greenfield E., Kuchroo V., Terhorst C., The role of SAP in murine CD150 (SLAM)-mediated T-cell proliferation and interferon production Blood 2002 100 8 2899 2907
41. Howie D., Simarro M., Sayos J., Guirado M., Sancho J., Terhorst C., Molecular dissection of the signaling and costimulatory functions of CD150 (SLAM): CD150/SAP binding and CD150-mediated costimulation Blood 2002 99 3 957 965 (Pubitemid 34525558)
42. Henning G., Kraft M. S., Derfuss T., Pirzer R., De Saint-Basile G., Aversa G., Fleckenstein B., Meinl E., Signaling lymphocytic activation molecule (SLAM) regulates T cellular cytotoxicity European Journal of Immunology 2001 31 9 2741 2750 (Pubitemid 32898742)
43. Mehrle S., Schmidt J., Bchler M. W., Watzl C., Mrten A., Enhancement of anti-tumor activity in vitro and in vivo by CD150 and SAP Molecular Immunology 2008 45 3 796 804 (Pubitemid 47498570)
44. Castro A. G., Hauser T. M., Cocks B. G., Abrams J., Zurawski S., Churakova T., Zonin F., Robinson D., Tangye S. G., Aversa G., Nichols K. E., De Vries J. E., Lanier L. L., O'Garra A., Molecular and functional characterization of mouse signaling lymphocytic activation molecule (SLAM): differential expression and responsiveness in Th1 and Th2 cells Journal of Immunology 1999 163 11 5860 5870
45. Mikhalap S. V., Shlapatska L. M., Berdova A. G., Law C. L., Clark E. A., Sidorenko S. P., CDw150 associates with Src-homology 2-containing inositol phosphatase and modulates CD95-mediated apoptosis Journal of Immunology 1999 162 10 5719 5727 (Pubitemid 29314922)
46. Nagy N., Matskova L., Hellman U., Klein G., Klein E., The apoptosis modulating role of SAP (SLAM associated protein) contributes to the symptomatology of the X linked lymphoproliferative disease Cell Cycle 2009 8 19 3086 3090
47. Henning G., Kraft M. S., Derfuss T., Pirzer R., De Saint-Basile G., Aversa G., Fleckenstein B., Meinl E., Signaling lymphocytic activation molecule (SLAM) regulates T cellular cytotoxicity European Journal of Immunology 2001 31 9 2741 2750 (Pubitemid 32898742)
48. Czar M. J., Kersh E. N., Mijares L. A., Lanier G., Lewis J., Yap G., Chen A., Sher A., Duckett C. S., Ahmed R., Schwartzberg P. L., Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP Proceedings of the National Academy of Sciences of the United States of America 2001 98 13 7449 7454 (Pubitemid 32567969)
49. Cannons J. L., Yu L. J., Hill B., Mijares L. A., Dombroski D., Nichols K. E., Antonellis A., Koretzky G. A., Gardner K., Schwartzberg P. L., SAP regulates TH2 differentiation and PKC- -mediated activation of NF- B1 Immunity 2004 21 5 693 706 (Pubitemid 39489893)
50. Valiante N. M., Trinchieri G., Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes Journal of Experimental Medicine 1993 178 4 1397 1406 (Pubitemid 23277371)
51. Garni-Wagner B. A., Purohit A., Mathew P. A., Bennett M., Kumar V., A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells Journal of Immunology 1993 151 1 60 70 (Pubitemid 23206971)
52. Nakajima H., Cella M., Langen H., Friedlein A., Colonna M., Activating interactions in human NK cell recognition: the role of 2B4-CD48 European Journal of Immunology 1999 29 5 1676 1683 (Pubitemid 29224473)
53. Schuhmachers G., Ariizumi K., Mathew P. A., Bennett M., Kumar V., Takashima A., Activation of murine epidermal T cells through surface 2B4 European Journal of Immunology 1995 25 4 1117 1120
54. Tangye S. G., Cherwinski H., Lanier L. L., Phillips J. H., 2B4-mediated activation of human natural killer cells Molecular Immunology 2000 37 9 493 501 (Pubitemid 32001691)
55. Ostrowski S. R., Ullum H., Pedersen B. K., Gerstoft J., Katzenstein T. L., 2B4 expression on natural killer cells increases in HIV-1 infected patients followed prospectively during highly active antiretroviral therapy Clinical and Experimental Immunology 2005 141 3 526 533 (Pubitemid 41075877)
56. Agrawal S., Marquet J., Freeman G. J., Tawab A., Le Bouteiller P., Roth P., Bolton W., Ogg G., Boumsell L., Bensussan A., Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells Journal of Immunology 1999 162 3 1223 1226 (Pubitemid 29306988)
57. Maeda M., Carpenito C., Russell R. C., Dasanjh J., Veinotte L. L., Ohta H., Yamamura T., Tan R., Takei F., Murine CD160, Ig-like receptor on NK Cells and NKT cells, recognizes classical and nonclassical MHC class I and regulates NK cell activation Journal of Immunology 2005 175 7 4426 4432 (Pubitemid 41361978)
58. Tsujimura K., Obata Y., Matsudaira Y., Nishida K., Akatsuka Y., Ito Y., Demachi-Okamura A., Kuzushima K., Takahashi T., Characterization of murine CD160 + CD8 + T lymphocytes Immunology Letters 2006 106 1 48 56 (Pubitemid 44093052)
59. Buttner P., Mosig S., Lechtermann A., Funke H., Mooren F. C., Exercise affects the gene expression profiles of human white blood cells Journal of Applied Physiology 2007 102 1 26 36 (Pubitemid 46089748)
60. Le Bouteiller P., Tabiasco J., Polgar B., CD160: a unique activating NK cell receptor Immunology Letters 2011 138 2 93 96
61. Maiza H., Leca G., Mansur I. G., Schiavon V., Boumsell L., Bensussan A., A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity Journal of Experimental Medicine 1993 178 3 1121 1126 (Pubitemid 23260453)
62. Rey J., Giustiniani J., Mallet F., Schiavon V., Boumsell L., Bensussan A., Olive D., Costello R. T., The co-expression of 2B4 (CD244) and CD160 delineates an subpopulation of human CD8 + T cells with a potent CD160-mediated cytolytic effector function European Journal of Immunology 2006 36 9 2359 2366 (Pubitemid 44420592)
63. Merino J., Ramrez N., Moreno C., Toledo E., Fernndez M., Snchez-Ibarrola A., BY55/CD160 cannot be considered a cytotoxic marker in cytomegalovirus- specific human CD8 + T cells Clinical and Experimental Immunology 2007 149 1 87 96 (Pubitemid 46897097)
64. Nikolova M. H., Muhtarova M. N., Taskov H. B., Kostov K., Vezenkov L., Mihova A., Boumsell L., Bensussan A., The CD160 + CD8high cytotoxic T cell subset correlates with response to HAART in HIV-1+ patients Cellular Immunology 2005 237 2 96 105 (Pubitemid 43117205)
65. Speiser D. E., Colonna M., Ayyoub M., Cella M., Pittet M. J., Batard P., Valmori D., Guillaume P., Liénard D., Cerottini J. C., Romero P., The activatory receptor 2B4 is expressed in vivo by human CD8 + effector T cells Journal of Immunology 2001 167 11 6165 6170 (Pubitemid 33081543)
66. Monney L., Sabatos C. A., Gaglia J. L., Ryu A., Waldner H., Chernova T., Manning S., Greenfield E. A., Coyle A. J., Sobel R. A., Freeman G. J., Kuchroo V. K., Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease Nature 2002 415 6871 536 541 (Pubitemid 34130609)
67. Hugues S., Fetler L., Bonifaz L., Helft J., Amblard F., Amigorena S., Distinct T cell dynamics in lymph nodes during the induction of tolerance and immunity Nature Immunology 2004 5 12 1235 1242 (Pubitemid 41057738)
68. Taylor R. C., Cullen S. P., Martin S. J., Apoptosis: controlled demolition at the cellular level Nature Reviews Molecular Cell Biology 2008 9 3 231 241 (Pubitemid 351301823)
69. Hughes P. D., Belz G. T., Fortner K. A., Budd R. C., Strasser A., Bouillet P., Apoptosis regulators Fas and Bim cooperate in shutdown of chronic immune responses andprevention of autoimmunity Immunity 2008 28 2 197 205 (Pubitemid 351215234)
70. Iezzi G., Karjalainen K., Lanzavecchia A., The duration of antigenic stimulation determines the fate of naive and effector T cells Immunity 1998 8 1 89 95 (Pubitemid 28097826)
71. Salomon B., Bluestone J. A., Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation Annual Review of Immunology 2001 19 225 252 (Pubitemid 32368035)
72. Collins A. V., Brodie D. W., Gilbert R. J. C., Iaboni A., Manso-Sancho R., Walse B., Stuart D. I., Van Der Merwe P. A., Davis S. J., The interaction properties of costimulatory molecules revisited Immunity 2002 17 2 201 210 (Pubitemid 35245962)
73. Greenwald R. J., Freeman G. J., Sharpe A. H., The B7 family revisited Annual Review of Immunology 2005 23 515 548 (Pubitemid 40563179)
74. Nakae S., Suto H., Iikura M., Kakurai M., Sedgwick J. D., Tsai M., Galli S. J., Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF Journal of Immunology 2006 176 4 2238 2248 (Pubitemid 43201671)
75. Ishida M., Iwai Y., Tanaka Y., Okazaki T., Freeman G. J., Minato N., Honjo T., Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues Immunology Letters 2002 84 1 57 62 (Pubitemid 34879920)
76. Latchman Y., Wood C. R., Chernova T., Chaudhary D., Borde M., Chernova I., Iwai Y., Long A. J., Brown J. A., Nunes R., Greenfield E. A., Bourque K., Boussiotis V. A., Carter L. L., Carreno B. M., Malenkovich N., Nishimura H., Okazaki T., Honjo T., Sharpe A. H., Freeman G. J., PD-L2 is a second ligand for PD-1 and inhibits T cell activation Nature Immunology 2001 2 3 261 268 (Pubitemid 33706004)
77. Freeman G. J., Long A. J., Iwai Y., Bourque K., Chernova T., Nishimura H., Fitz L. J., Malenkovich N., Okazaki T., Byrne M. C., Horton H. F., Fouser L., Carter L., Ling V., Bowman M. R., Carreno B. M., Collins M., Wood C. R., Honjo T., Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation Journal of Experimental Medicine 2000 192 7 1027 1034
78. Okazaki T., Honjo T., The PD-1-PD-L pathway in immunological tolerance Trends in Immunology 2006 27 4 195 201
79. Nishimura H., Nose M., Hiai H., Minato N., Honjo T., Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor Immunity 1999 11 2 141 151 (Pubitemid 29428807)
80. Nishimura H., Okazaki T., Tanaka Y., Nakatani K., Hara M., Matsumori A., Sasayama S., Mizoguchi A., Hiai H., Minato N., Honjo T., Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice Science 2001 291 5502 319 322 (Pubitemid 32096320)
81. Sedy J. R., Gavrieli M., Potter K. G., Hurchla M. A., Lindsley R. C., Hildner K., Scheu S., Pfeffer K., Ware C. F., Murphy T. L., Murphy K. M., B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator Nature Immunology 2005 6 1 90 98 (Pubitemid 40136700)
82. Krieg C., Boyman O., Fu Y. X., Kaye J., B and T lymphocyte attenuator regulates CD8 + T cell-intrinsic homeostasis and memory cell generation Nature Immunology 2007 8 2 162 171 (Pubitemid 46152647)
83. Cai G., Anumanthan A., Brown J. A., Greenfield E. A., Zhu B., Freeman G. J., CD160 inhibits activation of human CD4 + T cells through interaction with herpesvirus entry mediator Nature Immunology 2008 9 2 176 185
84. Wherry E. J., Blattman J. N., Murali-Krishna K., Van Der Most R., Ahmed R., Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment Journal of Virology 2003 77 8 4911 4927 (Pubitemid 36402840)
85. Sharpe A. H., Wherry E. J., Ahmed R., Freeman G. J., The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection Nature Immunology 2007 8 3 239 245 (Pubitemid 46745373)
86. Zajac A. J., Blattman J. N., Murali-Krishna K., Sourdive D. J. D., Suresh M., Altman J. D., Ahmed R., Viral immune evasion due to persistence of activated T cells without effector function Journal of Experimental Medicine 1998 188 12 2205 2213 (Pubitemid 29028493)
87. Velu V., Titanji K., Zhu B., Husain S., Pladevega A., Lai L., Vanderford T. H., Chennareddi L., Silvestri G., Freeman G. J., Ahmed R., Amara R. R., Enhancing SIV-specific immunity in vivo by PD-1 blockade Nature 2009 458 7235 206 210
88. Day C. L., Kaufmann D. E., Kiepiela P., Brown J. A., Moodley E. S., Reddy S., Mackey E. W., Miller J. D., Leslie A. J., DePierres C., Mncube Z., Duraiswamy J., Zhu B., Eichbaum Q., Altfeld M., Wherry E. J., Coovadia H. M., Goulder P. J. R., Klenerman P., Ahmed R., Freeman G. J., Walker B. D., PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression Nature 2006 443 7109 350 354 (Pubitemid 44435155)
89. Das A., Hoare M., Davies N., Lopes A. R., Dunn C., Kennedy P. T. F., Alexander G., Finney H., Lawson A., Plunkett F. J., Bertoletti A., Akbar A. N., Maini M. K., Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection Journal of Experimental Medicine 2008 205 9 2111 2124
90. Urbani S., Amadei B., Tola D., Massari M., Schivazappa S., Missale G., Ferrari C., PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion Journal of Virology 2006 80 22 11398 11403 (Pubitemid 44706581)
91. Nakamoto N., Cho H., Shaked A., Olthoff K., Valiga M. E., Kaminski M., Gostick E., Price D. A., Freeman G. J., Wherry E. J., Chang K. M., Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade PLoS Pathogens 2009 5 2
92. Kozako T., Yoshimitsu M., Fujiwara H., PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients Leukemia 2009 23 2 375 382
93. Lee P. P., Yee C., Savage P. A., Fong L., Brockstedt D., Weber J. S., Johnson D., Swetter S., Thompson J., Greenberg P. D., Roederer M., Davis M. M., Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients Nature Medicine 1999 5 6 677 685 (Pubitemid 29289432)
94. Akbar A. N., Henson S. M., Are senescence and exhaustion intertwined or unrelated processes that compromise immunity? Nature Reviews Immunology 2011 11 4 289 295
95. Ishida Y., Agata Y., Shibahara K., Honjo T., Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death EMBO Journal 1992 11 11 3887 3895
96. Barber D. L., Wherry E. J., Masopust D., Zhu B., Allison J. P., Sharpe A. H., Freeman G. J., Ahmed R., Restoring function in exhausted CD8 T cells during chronic viral infection Nature 2006 439 7077 682 687 (Pubitemid 43237609)
97. Petrovas C., Casazza J. P., Brenchley J. M., Price D. A., Gostick E., Adams W. C., Precopio M. L., Schacker T., Roederer M., Douek D. C., Koup R. A., PD-1 is a regulator of virus-specific CD8 + T cell survival in HIV infection Journal of Experimental Medicine 2006 203 10 2281 2292 (Pubitemid 44498363)
98. Harari A., Cellerai C., Enders F. B., Kstler J., Codarri L., Tapia G., Boyman O., Castro E., Gaudieri S., James I., John M., Wagner R., Mallal S., Pantaleo G., Skewed association of polyfunctional antigen-specific CD8 T cell populations with HLA-B genotype Proceedings of the National Academy of Sciences of the United States of America 2007 104 41 16233 16238 (Pubitemid 350099390)
99. Trautmann L., Janbazian L., Chomont N., Said E. A., Gimmig S., Bessette B., Boulassel M. R., Delwart E., Sepulveda H., Balderas R. S., Routy J. P., Haddad E. K., Sekaly R. P., Upregulation of PD-1 expression on HIV-specific CD8 + T cells leads to reversible immune dysfunction Nature Medicine 2006 12 10 1198 1202 (Pubitemid 44527357)
100. Boni C., Fisicaro P., Valdatta C., Amadei B., Di Vincenzo P., Giuberti T., Laccabue D., Zerbini A., Cavalli A., Missale G., Bertoletti A., Ferrari C., Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection Journal of Virology 2007 81 8 4215 4225 (Pubitemid 46586915)
101. Blank C., Kuball J., Voelkl S., Wiendl H., Becker B., Walter B., Majdic O., Gajewski T. F., Theobald M., Andreesen R., Mackensen A., Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro International Journal of Cancer 2006 119 2 317 327
102. Gehring A. J., Ho Z. Z., Tan A. T., Aung M. O., Lee K. H., Tan K. C., Lim S. G., Bertoletti A., Profile of tumor antigen-specific cd8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma Gastroenterology 2009 137 2 682 690
103. Ahmadzadeh M., Johnson L. A., Heemskerk B., Wunderlich J. R., Dudley M. E., White D. E., Rosenberg S. A., Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired Blood 2009 114 8 1537 1544
104. Mumprecht S., Schrch C., Schwaller J., Solenthaler M., Ochsenbein A. F., Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progression Blood 2009 114 8 1528 1536
105. Zhang L., Gajewski T. F., Kline J., PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model Blood 2009 114 8 1545 1552
106. Trautmann L., Janbazian L., Chomont N., Said E. A., Gimmig S., Bessette B., Boulassel M. R., Delwart E., Sepulveda H., Balderas R. S., Routy J. P., Haddad E. K., Sekaly R. P., Upregulation of PD-1 expression on HIV-specific CD8 + T cells leads to reversible immune dysfunction Nature Medicine 2006 12 10 1198 1202 (Pubitemid 44527357)
107. Blackburn S. D., Shin H., Haining W. N., Zou T., Workman C. J., Polley A., Betts M. R., Freeman G. J., Vignali D. A. A., Wherry E. J., Coregulation of CD8 + T cell exhaustion by multiple inhibitory receptors during chronic viral infection Nature Immunology 2009 10 1 29 37
108. Richter K., Agnellini P., Oxenius A., On the role of the inhibitory receptor LAG-3 in acute and chronic LCMV infection International Immunology 2009 22 1 13 23
109. Wherry E. J., Ha S. J., Kaech S. M., Haining W. N., Sarkar S., Kalia V., Subramaniam S., Blattman J. N., Barber D. L., Ahmed R., Molecular signature of CD8 + T cell exhaustion during chronic viral infection Immunity 2007 27 4 670 684 (Pubitemid 47615511)
110. Jones R. B., Ndhlovu L. C., Barbour J. D., Sheth P. M., Jha A. R., Long B. R., Wong J. C., Satkunarajah M., Schweneker M., Chapman J. M., Gyenes G., Vali B., Hyrcza M. D., Yue F. Y., Kovacs C., Sassi A., Loutfy M., Halpenny R., Persad D., Spotts G., Hecht F. M., Chun T. W., McCune J. M., Kaul R., Rini J. M., Nixon D. F., Ostrowski M. A., Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection Journal of Experimental Medicine 2008 205 12 2763 2779
111. Golden-Mason L., Palmer B. E., Kassam N., Townshend-Bulson L., Livingston S., McMahon B. J., Castelblanco N., Kuchroo V., Gretch D. R., Rosen H. R., Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4 + and CD8 + T cells Journal of Virology 2009 83 18 9122 9130
112. McMahan R. H., Golden-Mason L., Nishimura M. I., McMahon B. J., Kemper M., Allen T. M., Gretch D. R., Rosen H. R., Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity Journal of Clinical Investigation 2010 120 12 4546 4557
113. Vali B., Jones R. B., Sakhdari A., Sheth P. M., Clayton K., Yue F. Y., Gyenes G., Wong D., Klein M. B., Saeed S., Benko E., Kovacs C., Kaul R., Ostrowski M. A., HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression European Journal of Immunology 2010 40 9 2493 2505
114. Fourcade J., Sun Z., Benallaoua M., Guillaume P., Luescher I. F., Sander C., Kirkwood J. M., Kuchroo V., Zarour H. M., Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8 + T cell dysfunction in melanoma patients Journal of Experimental Medicine 2010 207 10 2175 2186
115. Sakuishi K., Apetoh L., Sullivan J. M., Blazar B. R., Kuchroo V. K., Anderson A. C., Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity Journal of Experimental Medicine 2010 207 10 2187 2194
116. Contardi E., Palmisano G. L., Tazzari P. L., Martelli A. M., Fal F., Fabbi M., Kato T., Lucarelli E., Donati D., Polito L., Bolognesi A., Ricci F., Salvi S., Gargaglione V., Mantero S., Alberghini M., Ferrara G. B., Pistillo M. P., CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction International Journal of Cancer 2005 117 4 538 550 (Pubitemid 41504541)
117. Boasso A., Vaccari M., Hryniewicz A., Fuchs D., Nacsa J., Cecchinato V., Andersson J., Franchini G., Shearer G. M., Chougnet C., Regulatory T-cell markers, indoleamine 2,3-dioxygenase, and virus levels in spleen and gut during progressive simian immunodeficiency virus infection Journal of Virology 2007 81 21 11593 11603 (Pubitemid 47623791)
118. Kaufmann D. E., Kavanagh D. G., Pereyra F., Zaunders J. J., Mackey E. W., Miura T., Palmer S., Brockman M., Rathod A., Piechocka-Trocha A., Baker B., Zhu B., Le Gall S., Waring M. T., Ahern R., Moss K., Kelleher A. D., Coffin J. M., Freeman G. J., Rosenberg E. S., Walker B. D., Upregulation of CTLA-4 by HIV-specific CD4 + T cells correlates with disease progression and defines a reversible immune dysfunction Nature Immunology 2007 8 11 1246 1254 (Pubitemid 350011764)
119. Kaufmann D. E., Walker B. D., PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention Journal of Immunology 2009 182 10 5891 5897
120. Curran M. A., Kim M., Montalvo W., Al-Shamkhani A., Allison J. P., Combination CTLA-4 blockade and 4-1BB activation enhances tumor rejection by increasing T-cell infiltration, proliferation, and cytokine production PLoS ONE 2011 6 4
121. Derre L., Rivals J. P., Jandus C., Pastor S., Rimoldi D., Romero P., Michielin O., Olive D., Speiser D. E., BTLA mediates inhibition of human tumor-specific CD8 + T cells that can be partially reversed by vaccination Journal of Clinical Investigation 2010 120 1 157 167
122. Xu X. S., Zhang Z., Gu L. L., Wang F. S., [BTLA Characterization and its association with disease progression in patients with chronic HIV-1 infection.] Chinese Journal of Cellular and Molecular Immunology 2009 25 1158 1160
123. Zhang Z., Xu X., Lv J., B and T lymphocyte attenuator down-regulation by HIV-1 depends on type I interferon and contributes to T-cell hyperactivation Journal of Infectious Diseases 2011 203 11 1668 1678
124. Antonelli L. R. V., Mahnke Y., Hodge J. N., Porter B. O., Barber D. L., DerSimonian R., Greenwald J. H., Roby G., Mican J., Sher A., Roederer M., Sereti I., Elevated frequencies of highly activated CD4 + T cells in HIV+ patients developing immune reconstitution inflammatory syndrome Blood 2010 116 19 3818 3827
125. Matsuzaki J., Gnjatic S., Mhawech-Fauceglia P., Beck A., Miller A., Tsuji T., Eppolito C., Qian F., Lele S., Shrikant P., Old L. J., Odunsi K., Tumor-infiltrating NY-ESO-1-specific CD8 + T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer Proceedings of the National Academy of Sciences of the United States of America 2010 107 17 7875 7880
126. Peritt D., Sesok-Pizzini D. A., Schretzenmair R., Macgregor R. R., Valiante N. M., Tu X., Trinchieri G., Kamoun M., C1.7 antigen expression on CD8 + T cells is activation dependent: increased proportion of C1.7+CD8 + T cells in HIV-1-infected patients with progressing disease Journal of Immunology 1999 162 12 7563 7568 (Pubitemid 29277738)
127. Aldy K. N., Horton N. C., Mathew P. A., Mathew S. O., 2B4+ CD8 + T cells play an inhibitory role against constrained HIV epitopes Biochemical and Biophysical Research Communications 2011 405 3 503 507
128. Williams H., Macsween K., McAulay K., Higgins C., Harrison N., Swerdlow A., Britton K., Crawford D., Analysis of immune activation and clinical events in acute infectious mononucleosis Journal of Infectious Diseases 2004 190 1 63 71 (Pubitemid 38858405)
129. Bengsch B., Seigel B., Ruhl M., Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8 + T cells is linked to antigen recognition and T cell differentiation PLoS Pathogens 2010 6 6
130. Raziorrouh B., Ulsenheimer A., Schraut W., Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4 + T cells in patients with chronic infection Gastroenterology 2011 141 4 1422 1431
131. Yamamoto T., Price D. A., Casazza J. P., Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8 + T-cell exhaustion in HIV infection Blood 2011 117 18 4805 4815
132. Kassu A., Marcus R. A., D'Souza M. B., Kelly-McKnight E. A., Golden-Mason L., Akkina R., Fontenot A. P., Wilson C. C., Palmer B. E., Regulation of virus-specific CD4 + T cell function by multiple costimulatory receptors during chronic HIV infection Journal of Immunology 2010 185 5 3007 3018
133. Lipson E. J., Drake C. G., Ipilimumab: an anti-CTLA-4 antibody for metastatic melanoma Clinical Cancer Research 2011 17 22 6958 6962
134. Danielli R., Ridolfi R., Chiarion-Sileni V., Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy Cancer Immunology, Immunotherapy 2012 61 1 41 48
135. Brahmer J. R., Drake C. G., Wollner I., Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates Journal of Clinical Oncology 2010 28 19 3167 3175
136. Kline J., Gajewski T. F., Clinical development of mAbs to block the PD1 pathway as an immunotherapy for cancer Current Opinion in Investigational Drugs 2010 11 12 1354 1359
137. Hodi F. S., Mihm M. C., Soiffer R. J., Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients Proceedings of the National Academy of Sciences of the United States of America 2003 100 8 4712 4717 (Pubitemid 36457795)
138. Phan G. Q., Yang J. C., Sherry R. M., Hwu P., Topalian S. L., Schwartzentruber D. J., Restifo N. P., Haworth L. R., Seipp C. A., Freezer L. J., Morton K. E., Mavroukakis S. A., Duray P. H., Steinberg S. M., Allison J. P., Davis T. A., Rosenberg S. A., Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma Proceedings of the National Academy of Sciences of the United States of America 2003 100 14 8372 8377 (Pubitemid 36842552)
139. Hryniewicz A., Boasso A., Edghill-Smith Y., Vaccari M., Fuchs D., Venzon D., Nacsa J., Betts M. R., Tsai W. -P., Heraud J. -M., Beer B., Blanset D., Chougnet C., Lowy I., Shearer G. M., Franchini G., CTLA-4 blockade decreases TGF-, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques Blood 2006 108 12 3834 3842 (Pubitemid 44864566)
140. Cecchinato V., Tryniszewska E., Ma Z. M., Vaccari M., Boasso A., Tsai W. P., Petrovas C., Fuchs D., Heraud J. M., Venzon D., Shearer G. M., Koup R. A., Lowy I., Miller C. J., Franchini G., Immune activation driven by CTLA-4 blockade augments viral replication at mucosal sites in simian immunodeficiency virus infection Journal of Immunology 2008 180 8 5439 5447